MAPT and dementia: The technique was effectively applied to the biological samples such as serum of the normal people, mild cognitive impairment patients, and dementia patients.46 An electrochemical immunosensor was assembled to detect tau protein in biological fluids as a neurodegenerative disease biomarker.